Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. (Q43081766)
Jump to navigation
Jump to search
scientific article published in May 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. |
scientific article published in May 2010 |
Statements
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design (English)
Jaw-Town Lin
Chi-Yang Chang
Mei-Jyh Chen
Chien-Chuan Chen